Exposure to the Functional Bacterial Amyloid Protein Curli Enhances Alpha-Synuclein Aggregation in Aged Fischer 344 Rats and Caenorhabditis elegans
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
Misfolded alpha-synuclein (AS) and other neurodegenerative disorder proteins display prion-like transmission of protein aggregation. Factors responsible for the initiation of AS aggregation are unknown. To evaluate the role of amyloid proteins made by the microbiota we exposed aged rats and transgenic C . elegans to E . coli producing the extracellular bacterial amyloid protein curli. Rats exposed to curli-producing bacteria displayed increased neuronal AS deposition in both gut and brain and enhanced microgliosis and astrogliosis compared to rats exposed to either mutant bacteria unable to synthesize curli, or to vehicle alone. Animals exposed to curli producing bacteria also had more expression of TLR2, IL-6 and TNF in the brain than the other two groups. There were no differences among the rat groups in survival, body weight, inflammation in the mouth, retina, kidneys or gut epithelia, and circulating cytokine levels. AS-expressing C . elegans fed on curli-producing bacteria also had enhanced AS aggregation. These results suggest that bacterial amyloid functions as a trigger to initiate AS aggregation through cross-seeding and also primes responses of the innate immune system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A study of Fischer-344 wild-type rats, which spontaneously develop asymptomatic α-synuclein pathology in the enteric nervous system in old age, showed that they will begin to develop pathological α-synuclein deposits in the brain and parkinsonian motor symptoms when their microbiome is disturbed through introduction of Escherichia coli [86, 87].”
From The gut–brain axis in early Parkinson’s disease: from prodrome to prevention (2025) · cites this paper as [86]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Exposure to curli-producing bacteria increases the deposition and accumulation of a-synuclein in intestinal ganglion cells (myenteric plexus and submucosa) and the brain, respectively, as well as increasing the inflammatory response in the brain.131”
From The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options (2021) · cites this paper as [131]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777 · cited 2×
“Our findings of microgliosis, astrogliosis and enhanced expression of IL-6, TLR2 and TNF in the brain following curli exposure suggest the occurrence of an enhanced local sterile inflammatory response to AS in the brain.”
The amyloid hypothesis of Alzheimer's disease at 25 years
Selkoe, D. J., & Hardy, J. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201606210 · Cited by 6,164 · cited 1×
“The precise role of protein aggregation and inflammation in neurodegeneration remains unclear 33 .”
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Regression Models for Ordinal Data
McCullagh, P. (1980) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1980.tb01109.x · Cited by 4,453
The Cellular Phase of Alzheimer’s Disease
De Strooper, B., & Karran, E. (2016) · Cell · doi:10.1016/j.cell.2015.12.056 · Cited by 1,990
Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synuclein
Desplats, P., Lee, H.-J., Bae, E.-J., Patrick, C., Rockenstein, E., Crews, L., Spencer, B., Masliah, E., & Lee, S.-J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903691106 · Cited by 1,485
Self-citationα-Synuclein strains cause distinct synucleinopathies after local and systemic administration
Peelaerts, W., Bousset, L., Van der Perren, A., Moskalyuk, A., Pulizzi, R., Giugliano, M., Van den Haute, C., Melki, R., & Baekelandt, V. (2015) · Nature · doi:10.1038/nature14547 · Cited by 1,130
Peripheral education of the immune system by colonic commensal microbiota
Lathrop, S. K., Bloom, S. M., Rao, S. M., Nutsch, K., Lio, C.-W., Santacruz, N., Peterson, D. A., Stappenbeck, T. S., & Hsieh, C.-S. (2011) · Nature · doi:10.1038/nature10434 · Cited by 1,034 · cited 2×
“The following antibodies were used: α -synuclein (Syn-1; BD Bioscience, San Diego, CA); TNF α , glial fibrillary acidic protein (GFAP) (GA5), TH, and NeuN (Millipore, County Cork, Ireland); β -actin (Sigma-Aldrich, St Louis, MO); NF-κ B p65 and phospho-NF-κ B p65 (Cell Signaling, Beverly, MA); IL-1 β and IL6 (Abcam, C…”
Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota
Harach, T., Marungruang, N., Duthilleul, N., Cheatham, V., Mc Coy, K. D., Frisoni, G., Neher, J. J., Fåk, F., Jucker, M., Lasser, T., et al. (2017) · Scientific Reports · doi:10.1038/srep41802 · Cited by 901
Neutrophils promote Alzheimer's disease–like pathology and cognitive decline via LFA-1 integrin
Zenaro, E., Pietronigro, E., Bianca, V. D., Piacentino, G., Marongiu, L., Budui, S., Turano, E., Rossi, B., Angiari, S., Dusi, S., et al. (2015) · Nature Medicine · doi:10.1038/nm.3913 · Cited by 865 · cited 1×
“It has recently been reported that circulating neutrophils contribute to AS pathology in transgenic mice 15 .”
Cited by
Items 301–400 of 463
Alpha synuclein overexpression can drive microbiome dysbiosis in mice
Sampson, T. R., Wallen, Z. D., Won, W.-J., Standaert, D. G., Payami, H., & Harms, A. S. (2025) · Scientific Reports · doi:10.1038/s41598-024-82139-7 · Cited by 11
Min, J.-H., Sarlus, H., & Harris, R. A. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1467333 · Cited by 14
Gorecki, A. M., Anyaegbu, C. C., Fitzgerald, M., Fuller, K. A., & Anderton, R. S. (2024) · Methods · doi:10.1016/j.ymeth.2024.10.009 · Cited by 11
The brain pathobiome in Alzheimer's disease
Shanmugam, N. K. N., Eimer, W. A., Kumar, D. K. V., & Tanzi, R. E. (2024) · Neurotherapeutics · doi:10.1016/j.neurot.2024.e00475 · Cited by 12
Lee, J., Jo, S., Lee, J., Choi, M., Kim, K., Lee, S.-J., Kim, H. S., Bae, J., & Chung, S. J. (2025) · Microbiome · doi:10.1186/s40168-025-02095-w · Cited by 13
“Escherichia coli has recently garnered attention due to its potential link with PD pathogenesis, especially because of its ability to generate curli amyloid fibrils [10–12 , 68– 70].”
Aging, Parkinson’s Disease, and Models: What Are the Challenges?
Bellantuono, I., Mortiboys, H., Rocha, E. M., Chamoli, M., Chinta, S. J., Andersen, J. K., Wallis, R., Bézard, E., Goldberg, M., Greenamyre, T., et al. (2023) · doi:10.59368/agingbio.20230010 · Cited by 16
“…doesn ’ t exacerbate paraquat-induced SN DA loss 251 α -synuclein inclusions in the heart and enteric nervous system 133 Overexpression Human WT 137,252 Alterations in DA vesicular clustering 137 WT and A30P α -synuclein exacerbates MPTP e ff ects 252 Point mutations (A53T prp 253 , A30P Thy-1 254 )”
BackgroundHansen, B., Laczny, C. C., Aho, V. T. E., Frachet-Bour, A., Habier, J., Ostaszewski, M., Michalsen, A., Hanslian, E., Koppold, D. A., Hartmann, A. M., et al. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-071380 · Cited by 13
Endres, K. (2020) · Molecules · doi:10.3390/molecules25040925 · Cited by 11
“elegans model with muscular expression of α-synuclein increased aggregation of these peptides in the worm [90].”
BackgroundVavougios, G. D., Nday, C. M., Pelidou, S., Zarogiannis, S. G., Gourgoulianis, K. I., Stamoulis, G. I., & Doskas, T. K. (2020) · Molecular Immunology · doi:10.1016/j.molimm.2020.08.021 · Cited by 10
Introducing the Extrabiome and Its Classification: A New View on Extracellular Nucleic Acids
Tetz, G. V., & Tetz, V. (2023) · Future Microbiology · doi:10.2217/fmb-2023-0003 · Cited by 9
Prebiotics and probiotics and Parkinson's disease
Amani, R., & Mehrabani, S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-90052-2.00034-2 · Cited by 9
Shi, M., Fan, H., Liu, H., & Zhang, Y. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1435778 · Cited by 9
Peng, B., Xu, S., Liang, Y., Dong, X., & Sun, Y. P. (2023) · Biomimetics · doi:10.3390/biomimetics8060459 · Cited by 11
“Studies have shown that the interaction of bacterial amyloids produced by intestinal flora and pathogenic amyloids related to neurodegenerative diseases may be one of the main triggers of AD [12,13].”
BackgroundAn, D., & Xu, Y. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e30175 · Cited by 13
Body-first Parkinson’s disease and variant Creutzfeldt–Jakob disease – similar or different?
Woerman, A. L., & Tamgüney, G. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105625 · Cited by 9
“elegans expressing human α-synuclein (Chen et al., 2016).”
Butnaru, D., & Chapman, J. (2019) · Autoimmunity Reviews · doi:10.1016/j.autrev.2018.09.009 · Cited by 10
Fecal Microbiome Transplants For Parkinson Disease
Sampson, T. R. (2024) · JAMA Neurology · doi:10.1001/jamaneurol.2024.2293 · Cited by 9
Disease mechanisms as subtypes: Microbiome
Bonvegna, S., & Cilia, R. (2023) · Handbook of clinical neurology · doi:10.1016/b978-0-323-85555-6.00006-0 · Cited by 8
Oh my gut! Is the microbial origin of neurodegenerative diseases real?
Walker, A. C., & Czyż, D. M. (2023) · Infection and Immunity · doi:10.1128/iai.00437-22 · Cited by 12
Mechanisms of oral microflora in Parkinson's disease
Wang, B., Zhang, C. M., Shi, C., Zhai, T., Zhu, J., Wei, D., Shen, J., Liu, Z., Jia, K., & Zhao, L. (2024) · Behavioural Brain Research · doi:10.1016/j.bbr.2024.115200 · Cited by 12
SynBio and the Boundaries between Functional and Pathogenic RepA-WH1 Bacterial Amyloids
Giraldo, R. (2020) · mSystems · doi:10.1128/msystems.00553-20 · Cited by 8
“sequence-unrelated mammalian proteins (36, 37, 77), intracellular aggregation occurred only in recipient cells expressing soluble RepA-WH1(wt), which could be molded into amyloid upon binding the internalized aggregates (76).”
BackgroundDirect Modulation of the Gut Microbiota as a Therapeutic Approach for Alzheimer’s Disease
Wang, Y., & Dykes, G. A. (2021) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527320666210806165751 · Cited by 8
Microbiota–Gut–Brain Axis: Pathophysiological Mechanism in Neuropsychiatric Disorders
Shin, C., & Kim, Y. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-981-19-7376-5_2 · Cited by 11
Białoń, N., Górka, H. N. O. Z. D., & Górka, M. (2024) · AIMS neuroscience · doi:10.3934/neuroscience.2024019 · Cited by 8
“These lipopolysaccharides are thought to be involved in the development of the inflammatory response in the brain, and their amount was directly proportional to the severity of cognitive impairment [60].”
BackgroundTian, C., Yang, M., Chen, K., Luo, D., Yue, N.-N., Zhao, H., Zhang, Y., Lu, J., Liang, Y.-J., Song, Y., et al. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s514838 · Cited by 9
Figura, M., Milanowski, Ł., Nowak, J. M., Antoniak, A., Kopczyński, M., Zając, W., Sadowski, K., Hołubiuk, Ł., Walęcik-Kot, W., Szlufik, S., et al. (2026) · Annals of Neurology · doi:10.1002/ana.78153 · Cited by 14
The microbiota–mitochondria axis: linking metabolic dysfunction to neurodegeneration
Yosefi, S., Babaeizad, A., Tabibian, S. S., Bahar, A., & Eslami, M. (2026) · Metabolic Brain Disease · doi:10.1007/s11011-026-01914-9 · Cited by 7
“Compared to the control strain, oral administration of curli-producing E. coli led to increased inflammation and more alpha-synuclein deposits in the brain (Chen et al. 2016 ).”
The role of gut-derived short-chain fatty acids in Parkinson's disease
Saadh, M. J., Mustafa, A. N., Mustafa, M. A., Renuka Jyothi, S., Dabis, H. K., Prasad, G. V. S., Mohammad, I. J., Adnan, A., & Idan, A. H. (2024) · Neurogenetics · doi:10.1007/s10048-024-00779-3 · Cited by 9
“Furthermore, animal models that were exposed to curli produced by intestinal bacteria exhibited increased expression of tumor necrosis factor, interleukin-6, and TLR2, in addition to facilitating the deposition of α ‐ syn in the brain [97].”
Conversion of the OmpF Porin into a Device to Gather Amyloids on the E. coli Outer Membrane
Vendrell-Fernández, S., Lozano-Picazo, P., Cuadros-Sánchez, P., Tejero-Ojeda, M. M., & Giraldo, R. (2021) · ACS Synthetic Biology · doi:10.1021/acssynbio.1c00347 · Cited by 8
Crosstalk between the aging intestinal microflora and the brain in ischemic stroke
Pluta, R. M., Jabłoński, M., Januszewski, S., & Czuczwar, S. J. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.998049 · Cited by 7
“Microbial amyloids induce nucleation of amyloid aggregates with high accumulation and an inflammatory response (Chen et al., 2016; Friedland and Chapman, 2017).”
BackgroundA role of human microbiota in the development of neurodegenerative diseases
Epishina, I. V., & Budanova, E. V. (2022) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro202212210157 · Cited by 12
Radisavljevic, N., Metcalfe‐Roach, A., Cirstea, M. S., Tabusi, M., Bozorgmehr, T., Bar‐Yoseph, H., & Finlay, B. B. (2023) · mSphere · doi:10.1128/msphere.00379-23 · Cited by 13
“…pathways decreased in LDCD-treated mice included one involving curli production [which has been shown to promote alpha-synuclein aggregation (25, 26)], those involved with the production of immunogenic components [lipopolysaccharide (LPS), bacterial lipoprotein (BLP), and lipoteichoic acid…”
BackgroundMohammadi, K., Zhang, D., & Saris, P. E. J. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-01102-z · Cited by 8
“Similarly, E. coli expressing the bacterial amyloid curli enhances α -syn aggregation via cross-seeding mechanisms, leading to mitochondrial dysfunction and neurotoxicity 25 .”
Targeting the gut microbiome for non-communicable diseases: present and future
Shivani, S., Chattopadhyay, A. S., & Chuang, E. Y.-Y. (2021) · Annals of Translational Medicine · doi:10.21037/atm-21-144 · Cited by 5
“coli displayed increased neuronal alpha-synuclein deposition in both the gut and brain, and enhanced microgliosis and astrogliosis compared to rats exposed to bacteria unable to produce curli (23).”
BackgroundAssociations Between Plasma Orexin-A Level and Constipation in Cognitive Impairment
Yang, M., Gan, J., Liu, S., Yang, Y., Han, J., Meng, Q., Yang, F., & Ji, Y. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230625 · Cited by 6
“The mouse models of AD revealed that amyloid produced by the bacterial strain contributes to AD pathology by promoting misfolding of A (cid:2) oligomers and fibrils [9–11].”
De, S., Banerjee, S., Rakshit, P., Banerjee, S., & Kumar, S. K. A. (2024) · Current Diabetes Reviews · doi:10.2174/0115733998291968240429111357 · Cited by 9
Disease modifying therapies for Parkinson's disease: Novel targets
Vijiaratnam, N., & Foltynie, T. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108839 · Cited by 7
“…et al., 2016) This process of peripheral accumulation is potentially triggered by exposure to bacteria which produce bacterial amyloid proteins(Chen et al., 2016) with animal studies suggesting that microbiota are involved in motor impairments by virtue of gut–brain signalling by microbial…”
BackgroundQamar, M. A., Tall, P., van Wamelen, D. J., Wan, Y.-M., Rukavina, K., Fieldwalker, A., Matthew, D., Leta, V., Bannister, K., & Chaudhuri, К. R. (2023) · International review of neurobiology · doi:10.1016/bs.irn.2023.08.012 · Cited by 10
Impact of the Microbiome on the Human Genome
Jeyakumar, T., Beauchemin, N., & Gros, P. (2019) · Trends in Parasitology · doi:10.1016/j.pt.2019.07.015 · Cited by 8
Impact of amyloid-like ovalbumin fibril consumption on health-related markers: An in vitro approach
Luyckx, T., Grootaert, C., Delcour, J. A., Housmans, J. A. J., Rousseau, F., Schymkowitz, J. W. H., Carpentier, S., & Camp, J. V. (2025) · Food Research International · doi:10.1016/j.foodres.2025.116288 · Cited by 5
Nanocarriers to mediate the pathways from diabetes toward Parkinson's disease
De, S., & Kuo, Y. (2024) · Journal of the Taiwan Institute of Chemical Engineers · doi:10.1016/j.jtice.2024.105401 · Cited by 6
The Alzheimer–E. coli Axis: What Can We Learn from an Electronic Health Record Platform
Katz, J., & Gao, H. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-215004 · Cited by 5
“LPS and E. coli K99 were detected immunocytochemically in brain parenchyma and vessels in all AD and control brains, DNA sequencing confirmed E. coli DNA in human control and AD brains [11].”
Use of Prebiotics for Addressing Gut Dysbiosis and Achieving Healthy Gut–Brain Axis
Lasrado, L. D., & Rai, A. K. (2022) · Springer eBooks · doi:10.1007/978-981-16-8444-9_11 · Cited by 7
A crate of Pandora: do amyloids from bacteria promote Alzheimer’s disease?
Nguyen, V. T. T., & Endres, K. (2020) · Neural Regeneration Research · doi:10.4103/1673-5374.297074 · Cited by 5
“…showed the possible effect of bacterial biomolecules on neurodegenerative disorders: aged Fisher 344 rats that already possess aggregated α-synuclein in the intestinal submucosal plexus showed aggravated protein deposits - not only in the gut but a lso in the hippocampus (Chen et al., 2016).”
BackgroundStructural analysis of the bacterial amyloid curliPreprint
Sleutel, M., Pradhan, B., & Remaut, H. K. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.02.28.482343 · Cited by 5
Indig, R. Y., & Landau, M. (2023) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2023.102318 · Cited by 5
Bacterial products initiation of alpha-synuclein pathology: an in vitro study
Ioghen, O. C., Gaina, G. F., Lambrescu, I. M., Manole, E., Pop, S., Niculescu, T., Mosoia, O., Ceafalan, L. C., & Popescu, B. O. (2024) · Scientific Reports · doi:10.1038/s41598-024-81020-x · Cited by 8
Golan, N., Parizat, A., Tabachnikov, O., Barnea, E., Olsen, W. P., Otzen, D. E., & Landau, M. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.108096 · Cited by 8
Curli protein: A potential contributor to α-synucleopathy in Parkinson's disease
Ghosh, N., & Sinha, K. (2025) · Translational Medicine of Aging · doi:10.1016/j.tma.2025.02.002 · Cited by 6
Biswal, B., Satapathy, B. S., Maharana, L., & Pattnaik, S. (2025) · Journal of Dispersion Science and Technology · doi:10.1080/01932691.2025.2488455 · Cited by 4
“[127] Furthermore, the activation of microglia impedes phagocytosis, which results in the build-up of A b 42.”
Randhawa, S., Saini, T. C., Bathla, M., Teji, N., & Acharya, A. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00868 · Cited by 4
Parkinson’s disease beyond the brain: implications for treatments
Naeini, S. M., Lopez, M. D., Fraser, P. E., & Tandon, A. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1600782 · Cited by 4
Indigenous gut microbes modulate neural cell state and neurodegenerative disease susceptibility
Blackmer‐Raynolds, L., Lipson, L. D., Kozlov, A., Yang, A., Hill, E. J., Sampson, M. M., Hamilton, A. M., Fraccaroli, I., Kelly, S. D., Chopra, P., et al. (2026) · Cell Systems · doi:10.1016/j.cels.2025.101481 · Cited by 6
“31–34 Our data herein expand on this observation, identifying specific brain transcriptional responses evoked by the presence of E. coli within the microbiome that may contribute to detrimental outcomes across a range of neurological contexts.”
Shukla, R., Singh, S., & Mishra, K. (2024) · Proceedings of the National Academy of Sciences India Section B Biological Sciences · doi:10.1007/s40011-023-01527-7 · Cited by 4
“Such findings suggest that bacterial amyloid acts as a trigger to initiate α-synuclein and other neurodegenerative amyloid like protein aggregation via cross-seeding and these bacterial amy-loids also primes innate immune system responses [1, 17].”
Shiraz, M. G., Nielsen, J., Widmann, J., Chung, K. H. K., Davis, T. P., Rasmussen, C. B., Scavenius, C., Enghild, J. J., Martin‐Gallausiaux, C., Singh, Y., et al. (2024) · Molecules and Cells · doi:10.1016/j.mocell.2024.100161 · Cited by 4
Pathogenesis-Associated Bacterial Amyloids: The Network of Interactions
Fayoud, H. J., Belousov, M. V., Antonets, K. S., & Nizhnikov, A. A. (2024) · Biochemistry (Moscow) · doi:10.1134/s0006297924120022 · Cited by 6
“12-13 12-13 2024 bacteria promoted α-Syn deposition and neuroinflammation in rats and transgenic Caenorhabditis elegans [212].”
Halimi, H., Ahmadi, B., Asri, N., Rostami‐Nejad, M., & Houri, H. (2025) · Microbial Pathogenesis · doi:10.1016/j.micpath.2025.107363 · Cited by 8
Microbial Trojan Horses: Virulence Factors as Key Players in Neurodegenerative Diseases
Grahl, M. V. C., Hohl, K. S., Smaniotto, T. Â., & Carlini, C. R. (2025) · Molecules · doi:10.3390/molecules30030687 · Cited by 5
“…producing Curli showed a reduction in the number of cholinergic neurons; extensive demyelination of white matter in the lumbar spinal cord; increased mRNA expression of Ceclin, p62 (an autophagy marker), and Murf1; elevated inflammatory markers; and increased α -synuclein aggregation [266,293,294]”
Multimodal methods to study protein aggregation and fibrillation
Herrera, M. G., Giampà, M., Tonali, N., & Dodero, V. I. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90264-9.00006-4 · Cited by 7
Navigating the Role and Approach of Gut Microbiota in Addressing Alzheimer's Disease Pathogenesis
Jazuli, I., Jazeel, A., Selvaratnam, L., Alex, D., & Kumari, Y. (2024) · Progress In Microbes & Molecular Biology · doi:10.36877/pmmb.a0000454 · Cited by 10
“An increase of TLR2-II6 and TNF was also found in exposed mice, leading to Friedland and Chapman proposing the term “Mapranosis,” describing the process of proteopathy and neuroinflammation linked to microbiota [32, 76, 77] .”
A Review of the Relationship Between Gut Microbiota and Memory
Benmelouka, A. Y., Sherif, A., & Ebada, M. A. (2019) · Springer eBooks · doi:10.1007/978-981-13-9636-6_8 · Cited by 5
Sobieszczańska, B., Pawłowska, B., Duda-Madej, A., Pawlik, K., Wiśniewski, J. Ł., Grzegrzółka, J., Turniak, M., Walczuk, U., & Gamian, A. (2019) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2019.05.001 · Cited by 4
Choi, Y., Shin, Y.-J., Huh, E., Lee, H., Park, S., Kim, J. H., Lee, S., Park, Y., Park, M. G., Kim, D., et al. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.106093 · Cited by 5
Roy, S., Chattopadhyay, D., Choudhury, L., Ghosh, S., & Mahajan, A. A. (2025) · Discover Neuroscience · doi:10.1186/s13064-025-00221-w · Cited by 6
“Most significantly, curli depletion, either pharmacologically or genetically, was able to reverse this [99].”
Chi, F., Chen, K., Yin, Y., Hakovirta, J. R., & Saris, P. E. J. (2026) · Sustainable Microbiology · doi:10.1093/sumbio/qvag002 · Cited by 7
Cortés, H., Lima, E. J., Duarte‐Peña, L., Peña‐Corona, S. I., Almarhoon, Z. M., Kaverikana, R., Shetty, M. S., Shet, V. B., Manjeshwar, N., Sharifi‐Rad, J., et al. (2026) · Food Science & Nutrition · doi:10.1002/fsn3.71486 · Cited by 6
“A study on rats inoculated with Escherichia coli resulted in Aβ deposition in the gut and neurons in the brain, producing curly amyloid fibrils, and glial cell and astrocyte proliferation was also reported to be enhanced (Chen et al. 2016).”
Park, G., Chakrabarty, P., Efron, P. A., & Nagpal, R. (2025) · Essays in Biochemistry · doi:10.1042/ebc20253055 · Cited by 4
“…body disease cohorts, particularly patients with idiopathic REM sleep behavior disorder (RBD), have demonstrated the presence of α-synuclein, and gut microbes, including Escherichia coli , have been shown to promote α-synuclein-mediated neuroinflammation and motor deficits in rodent models [83–85].”
Gut microbiota in health and disease
Li, Y. N., Xiao, X., Jiang, X., Li, X., WANG, W., & Lin, R. (2026) · Molecular Biomedicine · doi:10.1186/s43556-026-00512-6 · Cited by 7
“Gut microbial dysbiosis can increase exposure to bacterial components and inflammatory stimuli, which may promote local innate immune activation and oxidative stress, and create a permissive microenvironment for α-synuclein misfolding and aggregation [327, 328].”
Neurodegenerative diseases: from gut-brain axis to brain microbiome
Friedland, R. P., & Haribabu, B. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1171955 · Cited by 4
Self-citationRole of the Intestinal Microbiota in the Molecular Pathogenesis of Atypical Parkinsonian Syndromes
Przewodowska, D., Alster, P., & Madetko‐Alster, N. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26093928 · Cited by 6
“It is suspected that the Curli subunit CsgA (extracellular bacterial amyloid protein) interacts with mammalian proteins in so-called cross-seeding, promoting α -synuclein accumulation [37].”
Microbiota-Brain-Gut Axis and Neurodegenerative Disorders
Abughazaleh, S. J., Euers, L. A., & Quigley, E. M. M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819265-8.00031-0 · Cited by 5
Perov, S., Lidor, O., Salinas, N., Golan, N., Tayeb-Fligelman, E., Deshmukh, M. G., Willbold, D., & Landau, M. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/493668 · Cited by 2
Microbiome-Derived Prion-Like Proteins and Their Potential to Trigger Cognitive DysfunctionPreprint
Curto, J. S., Martinez, A. D., Sotillo, P. S., Garcia, M. S., del Pozo, M. G., Fernández, M. R., & de Groot, N. S. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.10.19.563052 · Cited by 3
“Importantly, there is substantial evidence indicating that biofilm-forming proteins can influence the aggregation of neuronal proteins, thereby impacting the development of neurodegeneration 31,32,36,37 .”
BackgroundLiu, J., Wang, L., Su, L., Chen, J., & Su, R. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1654418 · Cited by 2
The gut microbiome in animal models of Parkinson’s disease
Morais, L. H., Fonseca, M. D. C., & Sampson, T. R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13550-7.00010-0 · Cited by 2
Luo, J., Luo, J., Zeng, L.-Y., & Chi, C.-L. (2025) · Medical Hypotheses · doi:10.1016/j.mehy.2025.111609 · Cited by 2
Quattrini, G., Gatti, E., Peretti, D. E., Aiello, M., Chevalier, C., Lathuilière, A., Park, R., Pievani, M., Salvatore, M., Scheffler, M., et al. (2025) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-025-07299-8 · Cited by 4
“Consistent with this hypothesis, an animal model knock-out in-vitro [77] as well as in PD rat models and C. elegans [78], and might argument inflammatory responses to endogenous amyloids [79].”
Role of the Gut Microbiome and Bacterial Amyloids in the Development of Synucleinopathies
Trubitsina, N. P., Matiiv, A. B., Rogoza, T. M., Zudilova, A. A., Bezgina, M. D., Zhouravleva, G. A., & Bondarev, S. A. (2024) · Biochemistry (Moscow) · doi:10.1134/s0006297924030118 · Cited by 3
Posautz, A., Loncaric, I., & Westermark, P. (2019) · Amyloid · doi:10.1080/13506129.2019.1593130 · Cited by 2
Schmit, K. J., Sciortino, A., Aho, V. T. E., Garcia, P., Rodriguez, B. P., Thomas, M. H., Gérardy, J., Halder, R., Cialini, C., Heurtaux, T., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.03.21.485143 · Cited by 2
Dopaminergic Medication Accentuates Fecal Gut Microbiome Changes in Parkinson’s DiseasePreprint
Boertien, J. M., Pereira, P. A., Laine, P., Paulin, L. G., van der Zee, S., Auvinen, P., Scheperjans, F., & van Laar, T. (2022) · medRxiv · doi:10.1101/2022.12.23.22283907 · Cited by 2
Microbiome-based biomarkers to guide personalized microbiome-based therapies for Parkinson’s diseasePreprint
Payami, H., Sampson, T. R., Murchison, C., & Wallen, Z. D. (2024) · medRxiv · doi:10.1101/2024.04.03.24305273 · Cited by 3
The interactions between gut and brain in psychiatric and neurological disorders
Shin, C., & Kim, Y. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821927-0.00010-3 · Cited by 4
Gut–Brain Axis: Role of Gut Microbiota in Neurodegenerative Disease
Narang, A., & Sandhir, R. (2022) · Springer eBooks · doi:10.1007/978-981-16-6760-2_1 · Cited by 1
Liu, Z., Lemus, J., Smirnova, I. V., & Liu, W. (2023) · Exploration of Neuroprotective Therapy · doi:10.37349/ent.2023.00049 · Cited by 3
Antimicrobial Peptides as Cross-Seeding Modulators at the Neurodegenerative–Infectious Interface
Zhang, Y., Tang, Y., Wang, L., & Zheng, J. (2026) · Research · doi:10.34133/research.1149 · Cited by 2
“Structural mimicry between microbial amyloids and neuronal proteins such as α -synuclein facilitates cross-seeding events that have been implicated in the initiation of α -synuclein aggregation within the enteric nervous system [ 50 , 58 , 70 ].”
Silent Intruders: The Gut Virome in Brain Aging and Cognitive Decline
Silvestro, S., Midiri, A., Biondo, C., Casilli, S., Borrello, L., Zummo, S., & Mancuso, G. (2026) · Pathogens · doi:10.3390/pathogens15020180 · Cited by 2
“It can also activate the innate immune system and facilitate α -syn aggregation and neuroinflammation [87].”
Microbiota as a regulator of brain vulnerability across lifespan and disease contexts
Santerre, M., Shcherbik, N., & Sawaya, B. E. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03824-0 · Cited by 1
“These structures share cross-β sheet architecture with human Aβ and can promote aggregation in experimental systems [55].”
Nanomechanical properties of steric zipper globular structures
Lester-Zer, N., Ghrayeb, M., & Chai, L. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1908782116 · Cited by 2
“Surprising recent findings link between the human and the functional amyloid proteins, suggesting that gut microbes produce functional amyloid proteins that affect neurodegeneration in humans (6, 7).”
BackgroundClinical and Pre-Clinical Evidence for Enteric α-Synuclein Involvement in Parkinson's Disease
Kochman, E. M., Akhtar, K., Ali, A., & Shin Damian, S. (2021) · International Journal of Neurodegenerative Disorders · doi:10.23937/2643-4539/1710019 · Cited by 5
Spreading of alpha-synuclein pathology from the gut to the brain in Parkinson's disease
Jevans, B., & Monte, D. A. D. (2021) · International review of movement disorders · doi:10.1016/bs.irmvd.2021.08.004 · Cited by 1
The gut microbiome in neurodegenerative disorders
Abughazaleh, S. J., Euers, L. A., & Quigley, E. M. M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821039-0.00006-x · Cited by 1
LEVERAGING SMALL MOLECULES TO MODULATE THE MICROBIOME TO TREAT HUMAN DISEASES
Gulati, A., & Guo, X. (2022) · Medicinal chemistry reviews · doi:10.1021/mc-2022-vol57.ch16 · Cited by 1
Circulating Extracellular Vesicles as a Potential Mediator of Synuclein Pathology in the Gut
Sampson, T. R. (2024) · Movement Disorders · doi:10.1002/mds.29673 · Cited by 2
“20 In addition, the gut microbiome and SCFA signaling have established effects not only on the intestinal barrier, but on the permeability of the blood – brain-barrier (BBB).”
BackgroundThe Gut Microbiota and NDG: What Is the Interplay
Haiba, S., Idriss, S., & Awad, M. (2024) · Springer eBooks · doi:10.1007/978-981-19-3949-5_30-1 · Cited by 1
The impact of microbiological infections on neurodegenerative diseases
Dilawari, R., & Singh, E. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-28822-7.00016-7 · Cited by 1
Le microbiote, l’intestin et le cerveau
Boudin, H., Gonzales, J. A., Derkinderen, P., & Neunlist, M. (2018) · Phytothérapie · doi:10.3166/phyto-2018-0094 · Cited by 1
Inflammation, stress, and gut-brain axis as therapeutic targets in bipolar disorder
Vaccariello, E. D., & Nguyen, T. T. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821398-8.00008-4 · Cited by 2
Stavrovskaya, A. V., Даниленко, В. Н., Воронков, Д. Н., Гущина, А. С., Марсова, М. В., Olshansky, A. S., Yamshikova, N. G., & Illarioshkin, S. N. (2021) · Human Physiology · doi:10.1134/s0362119721080120 · Cited by 1
“Moreover, higher expression of TLR-2, TNF-α, and IL-6 was observed in the rat brain, indicating that amyloids produced by bacteria trigger α-Syn aggregation and, consequently, a response of the innate immunity system [49, 50].”
BackgroundFunctional amyloids in the microbiomes of a rat Parkinson’s disease model and wild-type ratsPreprint
Christensen, L. F. B., Alijanvand, S. H., Burdukiewicz, M. J., Herbst, F., Kjeldal, H., Dueholm, M. S., & Otzen, D. E. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.03.31.438001 · Cited by 1
“In support of the pro-aggregatory role of CsgA, the amount of αSN deposits in aged rats and C. elegans PD models was increased after being orally fed with curli-producing E.coli compared to animals that had been fed with a curli-deficient E. coli strain [19].”
Background
Metadata
- Authors
- Chen, S. G., Stribinskis, V., Rane, M. J., Demuth, D. R., Gozal, E., Roberts, A. M., Jagadapillai, R., Liu, R., Choe, K., Shivakumar, B., Son, F., Jin, S., Kerber, R., Adame, A., Masliah, E., & Friedland, R. P.
- Affiliations
- Case Western Reserve University (US)
- University of Louisville (US)
- University of California San Diego (US)
- Corresponding author
- Friedland, Robert P.
- ORCID
- Venue
- Scientific Reports
- Published
- 2016-10-06
- Volume
- 6
- Issue
- 1
- Pages
- 34477-34477
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC5052651
- OpenAlex
- W2528438579
- Semantic Scholar
- 8941d2a0855c5ed0f4d041db3a0b4426e019b757
- Cited by
- 463
- References
- 53
- Citations by year
- 2026: 27 · 2025: 44 · 2024: 62 · 2023: 57 · 2022: 72 · 2021: 74 · 2020: 45 · 2019: 45 · 2018: 17 · 2017: 19 · 2016: 1
- FWCI
- 20.56
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Michael J. Fox Foundation for Parkinson's Research
- University of Louisville
- National Institute on Aging (P50AG005131)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- alpha-synuclein aggregation, curli, bacterial amyloids, prion-like transmission, cross-seeding, gut microbiota, neuroinflammation, microglial activation, astrocyte activation, innate immune response, TLR2, interleukin-6, TNF-α, aged rats, Caenorhabditis elegans, Escherichia coli, neurodegenerative diseases
- MeSH terms
- Amyloid, Animals, Bacterial Proteins, Escherichia coli, Rats, Inbred F344, Caenorhabditis elegans, Escherichia coli Proteins, Rats, alpha-Synuclein, Protein Aggregation, Pathological
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.